A multicentre, international, randomised, open-label phase 3 trial of avelumab plus best supportive care (BSC) vs BSC alone as maintenance therapy after first-line platinum-based chemotherapy in patients with advanced urothelial cancer (JAVELIN bladder 100)

被引：5
|
作者：
Powles, T. [1 ]
Grivas, P. [2 ]
Aragon-Ching, J. B. [3 ]
Faroun, Y. [4 ]
Kessler, E. R. [5 ]
Tomita, Y. [6 ]
Chakrabarti, D. [7 ]
Laliberte, R. J. [7 ]
Shnaidman, M. [7 ]
Petrylak, D. [8 ]
机构：
[1] Royal Free Hosp, Med Oncol, London, England
[2] Cleveland Clin, Med Oncol, Cleveland, OH 44106 USA
[3] Inova Schar Canc Inst, Med Oncol, Fairfax, VA USA
[4] St Lukes Hosp & Hlth Network, Med Oncol, Bethlehem, PA USA
[5] Univ Colorado, Med Oncol, Anschutz Med Campus, Aurora, CO USA
[6] Niigata Univ, Grad Sch Med & Dent Sci, Urol, Niigata, Japan
[7] Pfizer Inc, Res, New York, NY USA
[8] Yale Canc Ctr, Med Oncol, New Haven, CT USA
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw373.69
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
842TiP
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial
    Machiels, Jean-Pascal
    Subramanian, Somasundaram
    Ruzsa, Agnes
    Repassy, Gabor
    Lifirenko, Igor
    Flygare, Annika
    Sorensen, Per
    Nielsen, Tina
    Lisby, Steen
    Clement, Paul M. J.
    [J]. LANCET ONCOLOGY, 2011, 12 (04): : 333 - 343
  • [32] MULTICENTRE PHASE III TRIAL COMPARING VINFLUNINE (V) PLUS BEST SUPPORTIVE CARE (BSC) VS BSC ALONE AS 2ND LINE THERAPY AFTER A PLATINUM-CONTAINING REGIMEN, IN ADVANCED TRANSITIONAL CELL CARCINOMA OF THE UROTHELIUM (TCCU)
    von der Maase, H.
    James, N.
    Winquist, E.
    Karyakin, O.
    Jagiello-Gruszfeld, A.
    Lorenz, J.
    van Herpen, C.
    Delgado, F.
    Salhi, Y.
    Bellmunt, J.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 202 - 202
  • [33] Meet-URO 12: A randomized phase II trial of niraparib versus best supportive care (BSC) as maintenance treatment in patients with locally advanced or metastatic urothelial cancer (UC) whose disease did not progress after completion of first-line platinum-based chemotherapy
    Vignani, F.
    Hamzaj, A.
    De Giorgi, U.
    Tambaro, R.
    Basso, U.
    Gamba, T.
    Ermacora, P.
    Santini, D.
    Capacci, S.
    Casadei, C.
    Pignata, S.
    Bimbatti, D.
    Giannatempo, P.
    Atzori, F.
    Cavanna, L.
    Veccia, A.
    Scandurra, G.
    Doni, L.
    Aieta, M.
    Di Maio, M.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S607 - S607
  • [34] Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
    Powles, Thomas
    Csoszi, Tibor
    Ozguroglu, Mustafa
    Matsubara, Nobuaki
    Geczi, Lajos
    Cheng, Susanna Y-S
    Fradet, Yves
    Oudard, Stephane
    Vulsteke, Christof
    Barrera, Rafael Morales
    Flechon, Aude
    Gunduz, Seyda
    Loriot, Yohann
    Rodriguez-Vida, Alejo
    Mamtani, Ronac
    Yu, Evan Y.
    Nam, Kijoeng
    Imai, Kentaro
    Moreno, Blanca Homet
    Alva, Ajjai
    [J]. LANCET ONCOLOGY, 2021, 22 (07): : 931 - 945
  • [35] Vinflunine maintenance therapy versus best supportive care (BSC) after platinum combination in advanced bladder cancer: A phase II, randomized, open-label study (MAJA study)-SOGUG 2011-02
    Macia, Sonia
    Garcia-Donas, Jesus
    Font Pous, Albert
    Domenech, Montserrat
    Garcia del Muro, Xavier
    Mellado, Begona
    Puente, Javier
    Arranz Arija, Jose Angel
    Climent Duran, Miguel Angel
    Lainez Milagro, Nuria
    Luis Perez-Gracia, Jose
    del Alba, Aranzazu Gonzalez
    Villa Guzman, Jose Carlos
    Perez-Valderrama, Begona
    Virizuela Echaburu, Juan
    Bonfill, Teresa
    Leon Mateos, Luis
    Morales-Barrera, Rafael
    Castellano, Daniel E.
    Bellmunt, Joaquim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [36] Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study
    Buikhuisen, Wieneke A.
    Burgers, Jacobus A.
    Vincent, Andrew D.
    Korse, Catharina M.
    van Klaveren, Rob J.
    Schramel, Franz M. N. H.
    Pavlakis, Nick
    Nowak, Anna K.
    Custers, Frank L. J.
    Schouwink, J. Hugo
    Gans, Steven J. M.
    Groen, Harry J. M.
    Strankinga, Wim F. M.
    Baas, Paul
    [J]. LANCET ONCOLOGY, 2013, 14 (06): : 543 - 551
  • [37] Avelumab first-line maintenance for advanced urothelial carcinoma in the phase 3 JAVELIN Bladder 100 trial: subgroup analysis by duration of treatment-free interval from end of chemotherapy to start of maintenance
    Pook, David
    Sridhar, Srikala
    Powles, Thomas
    Loriot, Yohann
    Duran, Climent Miguel
    Gupta, Shilpa
    Tsuchiya, Norihiko
    Bamias, Aristotelis
    Ardizzoni, Andrea
    Ullen, Anders
    Huang, Bo
    Costa, Nuno
    Laliberte, Robert
    di Pietro, Alessandra
    Sternberg, Cora
    Grivas, Petros
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 43 - 44
  • [38] Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy
    Bellmunt, J.
    Fougeray, R.
    Rosenberg, J. E.
    von der Maase, H.
    Schutz, F. A.
    Salhi, Y.
    Culine, S.
    Choueiri, T. K.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (06) : 1466 - 1472
  • [39] Avelumab (MSB0010718C; anti-PD-L1) + best supportive care (BSC) vs BSC chemotherapy as third-line treatment for patients with unresectable, recurrent, or metastatic gastric cancer: The phase 3 JAVELIN Gastric 300 trial.
    Bang, Yung-Jue
    Wyrwicz, Lucjan
    Park, Young Lee
    Ryu, Min-Hee
    Muntean, Alina
    Gomez-Martin, Carlos
    Guimbaud, Rosine
    Ciardiello, Fortunato
    Boku, Narikazu
    Van Cutsem, Eric
    Taieb, Julien
    Xiong, Huiling
    Zhang, Jenny
    Cuillerot, Jean-Marie
    Gurtler, Jayne S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [40] Avelumab first-line maintenance for advanced urothelial carcinoma (aUC) in the phase 3 JAVELIN Bladder 100 trial: Subgroup analysis by duration of treatment-free interval from end of chemotherapy to start of maintenance
    Pook, David W.
    Sridhar, Srikala S.
    Powles, Thomas
    Loriot, Yohann
    Duran, Miguel A. Climent
    Gupta, Shilpa
    Tsuchiya, Norihiko
    Bamias, Aristotelis
    Ardizzoni, Andrea
    Ullen, Anders
    Huang, Bo
    Costa, Nuno
    Laliberte, Robert J.
    di Pietro, Alessandra
    Sternberg, Cora N.
    Grivas, Petros
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 131 - 132
12345